| | | |  | | | | By Angus Chen Laura Brown for STAT A new type of lung-sparing surgery is starting to gain traction, and support through studies. But the details are fiercely debated among surgeons. Read More | | By Jonathan Wosen Images courtesy Calibr Researchers showed they could quell widespread inflammation often seen after CAR-T therapy within a couple days by switching the cells off. Read More | | By Rachel Cohrs Anna Moneymaker/Getty Images The White House is pitching an added benefit to Democrats’ recent drug pricing reform package: lower cancer death rates. Read More | | Sponsor content by Amgen Oncology 3 women making an impact in prostate cancer research This year alone in the U.S., 34,500 men are expected to lose their lives to prostate cancer. At Amgen, scientists are driving ambitious research into T-cell engagers, a growing field of cancer research with the potential to transform how we harness the human immune system to kill malignant tumors. Designed to attack new targets, their goal is to bring hope to men fighting the deadliest forms of prostate cancer. To learn more, read this story. | | By Allison DeAngelis Courtesy Bayer Its mandate is to find biotech and agriculture startups that might one day make for interesting R&D partners, or acquisition targets. Read More | |
No comments